| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/19/2005 | US6881829 Complexing drug with substance p |
| 04/19/2005 | US6881825 Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues |
| 04/19/2005 | US6881821 Hepatitis-C virus type 4, 5, and 6 |
| 04/19/2005 | US6881718 Discovery of novel disulfide linked cell toxins which can ablate NK-1 receptor expressing cells. These toxins are used as pharmaceutical compositions for the ablation of NK1 receptor expressing cells and comprise a substance P |
| 04/16/2005 | CA2480199A1 Fp-ghrelin |
| 04/14/2005 | WO2005033311A2 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | WO2005033307A1 Novel refolding method and protein obtained by the method |
| 04/14/2005 | WO2005032461A2 Novel peptide with osteogenic activity |
| 04/14/2005 | WO2004104039A8 Tumor antigens for prevention and/or treatment of cancer |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004062574A3 Improved linkers for radiopharmaceutical compounds |
| 04/14/2005 | WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/14/2005 | US20050080243 Screening for enzyme inhibitors; signal transduction passageways' chelation enhancement fluorescence |
| 04/14/2005 | US20050080242 Fluorescence assay for kinase activity |
| 04/14/2005 | US20050080234 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 04/14/2005 | US20050079568 Measuring protein kinase or phosphatase activity in a sample with a reporter peptide, or a fluorescently-labeled phosphorylatable reporter peptide, cleaved by a protease, without using antibodies or radioactive labels, bioassay |
| 04/14/2005 | US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
| 04/14/2005 | US20050079186 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals |
| 04/14/2005 | CA2542002A1 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | CA2524209A1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 04/13/2005 | EP1521841A1 Method for identifying individual active entities from complex mixtures |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1259535B1 Cyclic hexapeptide derivatives |
| 04/13/2005 | EP1073453B1 Use of angiotensin analogs for the manufacture of a medicament for increasing white blood cell survival and mobilizing haematopoietic progenitor cells following chemotherapy |
| 04/13/2005 | EP1049450B1 Skin and hair darkening composition |
| 04/13/2005 | EP0774971B1 Synthetic peptide inhibitors of hiv transmission |
| 04/13/2005 | CN1606450A Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon |
| 04/13/2005 | CN1605590A 10 peptide with cell protection function |
| 04/13/2005 | CN1196711C Chromatographic process for obtaining very pure cycloporin A and related cyclosporins |
| 04/12/2005 | US6878804 Coupling a solid support derived from polystyrene crosslinked with divinylbenzene which is functionalized by 2-chlrotrityl linker with an N-protected derivatives of preferential amino acid |
| 04/12/2005 | US6878375 HA-1 antigen |
| 04/12/2005 | CA2086672C Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 04/08/2005 | CA2445743A1 Methods for modulating neuronal responses |
| 04/07/2005 | WO2005030961A1 Novel nerve stem cell marker |
| 04/07/2005 | WO2005030797A2 Melanocortin receptor agonists |
| 04/07/2005 | WO2005030258A2 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 04/07/2005 | WO2005018657A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 04/07/2005 | WO2005010024A3 Potent peptide inhibitors and methods of use |
| 04/07/2005 | WO2005000893A3 Pharmaceutical composition comprising cyclic somatostin analogues |
| 04/07/2005 | WO2003064458A8 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 04/07/2005 | US20050075493 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 04/07/2005 | US20050075483 Vancomycin derivatives linked with disaccharide sugar, obtained by deprotecting a protected glycopeptide, by sulfonation, replacement; preparing a glycopeptide by glycosylation of an aglycone derived from glycopeptide antibiotic |
| 04/07/2005 | US20050075480 Urotensin-II agonists and antagonists |
| 04/07/2005 | US20050075281 Acylated nonadepsipeptides |
| 04/07/2005 | US20050075280 Novel antiarrythmic peptides |
| 04/07/2005 | US20050075278 Compositions of sunflower trypsin inhibitors |
| 04/07/2005 | US20050074884 Identification of peptides that facilitate uptake and cytoplasmic and /or nuclear transport of proteins, DNA and viruses |
| 04/07/2005 | US20050074863 Chemoprotective agent comprising lymphocyte epitopes for use in treatment of cell proliferative disorders |
| 04/07/2005 | US20050074817 Method for fabricating an olfactory receptor-based biosensor |
| 04/07/2005 | US20050074812 Molecules that home to various selected organs or tissues |
| 04/07/2005 | US20050074750 Using multi-epitope antigen to diagnose viral and micoorganismal infection |
| 04/07/2005 | US20050074747 Identifying peptide sequences that selectively bind to preferential bio-targets for use in diagnosis of viral disease, diabetes, inflammatory, arthritic, atherosclerotic, cell proliferative, autoimmune and cardiovascular disorders |
| 04/07/2005 | US20050074463 Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposes |
| 04/07/2005 | US20050074411 Synthesis of an magnetic resonance imaging (MRI) agent by reacting a peptide with p-xylylenediamine and covalently attaching a linker moiety, reacting with a precursor chelate moiety having protected carboxy groups, deprotecting, and chelating with a paramagnetic metal ion |
| 04/07/2005 | US20050072736 Purification process |
| 04/07/2005 | CA2540644A1 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 04/07/2005 | CA2539914A1 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 04/07/2005 | CA2539596A1 Melanocortin receptor agonists |
| 04/07/2005 | CA2539486A1 Methods for preparing oil bodies comprising active ingredients |
| 04/06/2005 | EP1520859A2 Hydrophilic signal oligopeptides and methods of therapeutic use |
| 04/06/2005 | EP1520178A2 Method for enriching and tracking pathologic modified prions-proteins (prp sp sc /sp ) |
| 04/06/2005 | EP1520174A2 Diagnostics method |
| 04/06/2005 | EP1519945A2 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
| 04/06/2005 | EP1224469B1 Method of screening for inhibitors of asp2 |
| 04/06/2005 | CN1604909A Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/06/2005 | CN1604908A Process for the preparation of echinocandin derivatives |
| 04/06/2005 | CN1603338A Selenium-containing polypeptide and its use in medicine, food etc |
| 04/06/2005 | CN1603337A Chemical synthesis method for inducing antibody immunogen against cell adhesion growth factor RGD |
| 04/06/2005 | CN1603336A Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes |
| 04/06/2005 | CN1195778C Cell adhension inhibitors |
| 04/06/2005 | CN1195776C Treatmet of obesity |
| 04/05/2005 | US6875843 Reducing the rate of islet cell infiltration by lymphocytes in a diabetes-susceptible mammal by administering a gonadotropin-releasing hormone antagonist. |
| 04/05/2005 | US6875741 Insulin and IGF-1 receptor agonists and antagonists |
| 04/05/2005 | US6875737 Multivalent compounds for crosslinking receptors and uses thereof |
| 04/05/2005 | US6875581 Identifying agonist and/or antagonist of calcium calmodulin-dependent protein kinases using laser fluctuation correlation spectroscopy; peptide mimetics; immunosuppressants |
| 04/05/2005 | CA2232344C Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028503A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | WO2005028502A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 03/31/2005 | WO2005016283A3 Peptides for enhanced cell attachment and growth |
| 03/31/2005 | WO2004087744A3 Composition and method for nerve regeneration |
| 03/31/2005 | WO2004064595A3 Multivalent constructs for therapeutic and diagnostic applications |
| 03/31/2005 | WO2003072754A3 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 03/31/2005 | US20050070470 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/31/2005 | US20050070466 Diagnostic imaging agents; targeting vectors which bind to integrin receptors; bicyclic arginine-glycine-aspartic acid derivatives; stablility; reduced background interference |
| 03/31/2005 | US20050070465 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
| 03/31/2005 | US20050070462 Contacting with cationic polymer |
| 03/31/2005 | US20050070028 Method for manufacturing antibody detector and method for detecting antibody |
| 03/31/2005 | US20050069916 Set of reporter signals use in detection of polymorphisms associated with metabolic and developmental disorders; multiplex detection and analysis of analytes and biomolecules |
| 03/31/2005 | US20050069494 Polypeptide; magnetic resonance imaging; diagnosis of cancer, osteoarthritis, infections, oral disease, rheumatic diseaeses, antiarthritic agents , cardiovascular disorders |
| 03/31/2005 | CA2539789A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | CA2538791A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 03/30/2005 | EP1517997A2 Luminogenic protease substrates |
| 03/30/2005 | EP1250093B1 Method for preventing fluorescence quenching |
| 03/30/2005 | EP1250092B1 Method for preventing fluorescence quenching |
| 03/30/2005 | EP1001978B1 Angiotensin derivatives |
| 03/30/2005 | EP0876610A4 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
| 03/30/2005 | EP0838474B1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient |